UBS Maintains Buy Rating on Teradyne, Cuts Price Target to $430
UBS cut its Teradyne price target to $430 per share from $485 while maintaining its Buy rating.
UBS cut its Teradyne price target to $430 per share from $485 while maintaining its Buy rating.